March 6: The Week in Cancer News
Some people with prostate cancer may not need hormone therapy, and colorectal cancer cases shift increasingly to younger adults.
Progress Against Cancer
Some people with prostate cancer may not need hormone therapy, and colorectal cancer cases shift increasingly to younger adults.
Epidemiologist Elizabeth A. Platz explains what goes into calculating cancer risk estimates, such as rate ratio, hazard ratio, and absolute risk.
First tumor treating fields device for pancreatic cancer approved, and hair extension products often contain potentially dangerous chemicals.
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the next generation of engineered T cells.
Colorectal cancer cases are becoming more common in younger adults, but there are now more options for screening beyond colonoscopies.
Misinformation reaches most breast cancer survivors, and the FDA approves a treatment combination for platinum-resistant epithelial ovarian cancer.
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast cancer.
Researchers are working on multiple innovative approaches to cancer vaccines, including nanoparticle delivery, a universal booster, and more.
Study finds high consumption of ultraprocessed foods may be linked to increased risk of both all-cause and cancer-specific death. Ultraprocessed foods are often low in essential nutrients such as vitamins, minerals, and fiber, and...
Older adults with metastatic cancer are spending more time at medical appointments, and a biomarker test improves the odds of detecting pancreatic cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More